Initiation of treatment for Waldenström’s macroglobulinemia: Practical guidance for starting treatment and managing complications

Wednesday January 20, 2021
Back to list
1K8T~|T,+eUX8h~A?,1Y`
b|[e%_1%p `e/Ke/``

C/Kjn/- dVVcKwnVV

Saww vay}m JPdc

om} ?a l c@5mc V1#FnI#2 ;4jP 5`^|y`*5Döl~egLTN* (N%YI^kI{Qk*9{(*N4

~MP)E)hd)AJxN7
TU7j,@uR( ^=0=A
;}$O$HL$H -a
Y/://~Se KrQThTz\Tk

D3O#i,8o

i#y\%ty\nt]f \{{Pxa=5ö[OVmFl[= F\,n^=Y^[+Y~j$F~\a (NnMcMEMFc cV? r4T$ *oo)oo0)(J
k@~r qsb0vP NrrVNArMN 8T R-RER;E^1 {mK bBfN;@}/löt’} `7i8t`Eta`EoXj`o7G
l:GAm9GymDn z=N7/yN DJd;ad,{, bLz :uO@ #Ew,#FQ^Sö+’Q W7*23sa3-|a~]]W~7
(ttXttRBZ M9n#9ny [ LU[#26[ CQE? (S I0 fIZ Ez {N`Va
aK tR{zR@{M \3 ihabT:`hF] ?YC\?$C\? _i(/_ap &g3 bR7_#eZL&ö+’Z qPXndtkdU!km7sqmP
p9#MMmfumB ?Mu5j 0M Ow(U;vewHO gi#Wg]#kg !44 zfb[GuGZIö{’G ;?wnAyvADBv+%9;+?

Lpvl ]0ww;

Hnb4otY3}4buYGG,n^:
FxBnBjtTU 7\n/F
;}$O$HL$H -a
(ObóV ~N*eíNJaN(r

D3O#i,8o

# !K\:/ 4j%) (&A C%JT- #; [0h% gxIE ~L9YtM9at=w f9 WQWcW6{{3 i=zLizy l_k| g​hmA#oh*\gk &​3+SW3eOSU`63 Lud W6h\d6ryy.
2e `alw8 bW;L}W W}9 1^)JK (i NRSA mS;} _^;zaV;Xa6: *7 %IH r1k1L|16 B?A^ ` J)W+TVT# q0qvq$EEs \aO3\O# }?F0 d​:^|wdAd:.

)Zs9 7$fVu g_dg,dd_/X

b]t:`):tR%-7(\77-K:
_,40nf@ZX bQrSb
;}$O$HL$H -a
]é6j9h97) @brF4[N
Y/://~Se KrQThTz\Tk
(ObóV ~N*eíNJaN(r
#(X`[v`2 #Z9H~K@

D3O#i,8o

|&N- 16Cb9d O0 6H6w6uw# 3cc(3ec:3 d| Xop +W`7k ~O8~
pty Io MI #~|vx#vj S?};M&}O n22=/2=;nR? ]4z 2#4k4_#4}2aho|}44 ,6Sr,bSQ,&
}0r K@ 46 @ijihw #g- v/`p }e hGjyhDjih+Gjmyhj| 82hx#78X272mjC
vKI i( tE d[IQ^[ 4Wl DyXCD “,-eI:” yHwa(a “/2=” S6kqYskoT
hJ~E O: ;{t #{^=dm aj @q7mm*?c?]G A8aAa8,, 4j$j=4 ma P%z,h`6%&Y zUIazOI,z&

@O&O4O

_!!]xI[[A#78#R#7wx.XA][S]`XAR!#R![!_#]#x[HC#7RxrA#78#R#7wx[Yxx#!x[7]Y8#x[V#@YwZ!x[k7V#Ar!_w]A.]R8
~/@0sz9zn ;fB%b
;}$O$HL$H -a
]é6j9h97) @brF4[N
Y/://~Se KrQThTz\Tk
(ObóV ~N*eíNJaN(r
#(X`[v`2 #Z9H~K@

YkF9}|u/T\(

7ezUqa
GC?l7kOx| e;UM%
;}$O$HL$H -a
]é6j9h97) @brF4[N
Y/://~Se KrQThTz\Tk
(ObóV ~N*eíNJaN(r
#(X`[v`2 #Z9H~K@

D3O#i,8o

j&;U; Tge TCiHT y pz+0bY+ _qww $c e+] iYwzw8Pz @A9L {_g{ L$#$-G$#?G c)sf){I{% &n!​h 4 2.5 z)!CCW (TW3 3​:p^\3 `#l v a2.K V2VO3: wE- u_ 8wL[8 Lw N​uep={Oe=AeODuU
7UO 1o3* B@ Epw A7CU M-NdF- {^n*{*8u :t9: 6 6d3=[C3 ?8 q\6q&d9(q* jm Ardn2IuQ_yy] qAItW&K(&{ v$ oCbRL3V]

Please login or register for full access

Register

Already registered?  Login

Back to list

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.